inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects at least 18 years of age 3. diabetic and obese (bmi \> 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr or rapid antigen test at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects at least 18 years of age 3. diabetic and obese (bmi \> 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr or rapid antigen test at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study healthy male or female subjects at least 18 years of age diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. positive test for covid-19 by rt-pcr or rapid antigen test at screening subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study healthy male or female subjects at least 18 years of age diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. positive test for covid-19 by rt-pcr or rapid antigen test at screening subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects at least 18 years of age 3. diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr or rapid antigen test at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects at least 18 years of age 3. diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr or rapid antigen test at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects 18 years of age to 75 years of age 3. diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy male or female subjects 18 years of age to 75 years of age 3. diabetic and obese (bmi > 30) patients will be included in the trial but randomization will be stratified. 4. positive test for covid-19 by rt-pcr at screening 5. subjects must agree to practice at least two highly effective methods of birth control for the duration of the study. one of these must be a barrier method. exceptions for females and partners of females that are not of childbearing potential. (e.g. surgically sterilized, post-menopausal) 6. subjects must agree they will attend the treatment facility daily for 10d in the event of failure to attend, the patient will be visited at their home to collect the nasal swab and review data.